In a bone metastatic PCa mouse model created with intratibial injections of PC3-luc-PSMA+ cells, the PSP-TRIM24 treatment significantly inhibited tumor growth and prevented bone loss compared to the control group (p < 0.01). Here, FOLH1 is linked to posterior cortical atrophy.